KPMG Video Insights information@kpmg.de https://videostream.kpmg.de de-de Visualplatform http://blogs.law.harvard.edu/tech/rss KPMG Video Insights Unser Podcast für Interessierte Banking episodic no https://videostream.kpmg.de/files/rv1.36/sitelogo.gif https://videostream.kpmg.de http://videostream.kpmg.de/webcast-navigating-csrd-reporting <p>The growing importance of ESG factors, propelled by ESG regulations, will transform sustainability reporting in the Life Sciences industry massively. Companies must consider environmental factors, such as water management, pollution, and circular economy, as well as social factors, such as own workforce, drug development, access to medicine and product safety and integrate them into business models and reporting landscapes.</p> <p>In our webcast "Navigating CSRD reporting in Life Sciences" on 14 March from 9:00 to 10:30 am CET, the participants learned from selected industry experts how leading Life Sciences companies are tackling this challenge and how they can successfully prepare themselves for ESG and sustainability reporting.</p><p><a href="http://videostream.kpmg.de/webcast-navigating-csrd-reporting"><img src="http://videostream.kpmg.de/64968578/84498186/01888094125b68a4021e44c09d568c7a/standard/download-12-thumbnail.jpg" width="75" height=""/></a></p> http://videostream.kpmg.de/photo/84498186 Tue, 14 Mar 2023 14:28:08 GMT Webcast: Navigating CSRD reporting in Life Sciences The growing importance of ESG factors, propelled by ESG regulations, will transform sustainability reporting in the Life Sciences industry massively. Companies must consider environmental factors, such as water management, pollution, and circular economy, as well as social factors, such as own workforce, drug development, access to medicine and product safety and integrate them into business models and reporting landscapes. In our webcast "Navigating CSRD reporting in Life Sciences" on 14 March from 9:00 to 10:30 am CET, the participants learned from selected industry experts how leading Life Sciences companies are tackling this challenge and how they can successfully prepare themselves for ESG and sustainability reporting. The growing importance of ESG factors, propelled by ESG regulations, will transform sustainability reporting in the Life Sciences industry massively. Companies must consider environmental factors, such as water management, pollution, and circular... KPMG Video Insights 01:28:25 <p>The growing importance of ESG factors, propelled by ESG regulations, will transform sustainability reporting in the Life Sciences industry massively. Companies must consider environmental factors, such as water management, pollution, and circular economy, as well as social factors, such as own workforce, drug development, access to medicine and product safety and integrate them into business models and reporting landscapes.</p> <p>In our webcast "Navigating CSRD reporting in Life Sciences" on 14 March from 9:00 to 10:30 am CET, the participants learned from selected industry experts how leading Life Sciences companies are tackling this challenge and how they can successfully prepare themselves for ESG and sustainability reporting.</p><p><a href="http://videostream.kpmg.de/webcast-navigating-csrd-reporting"><img src="http://videostream.kpmg.de/64968578/84498186/01888094125b68a4021e44c09d568c7a/standard/download-12-thumbnail.jpg" width="75" height=""/></a></p> csrd esg life science industry life sciences life sciences companies webcast webcast live http://videostream.kpmg.de/tax-implications-for-life-sciences <p><p>In many life sciences companies the corona pandemic has triggered developments with tax implications: for example, accelerated digitalization and re-nationalization of supply chains. Our expert Dr. Kai Reusch explains why tax authorities in many countries are interested in digital business models and how a relocation of supply chains affects the transfer pricing system and indirect tax position.</p></p><p><a href="http://videostream.kpmg.de/tax-implications-for-life-sciences"><img src="http://videostream.kpmg.de/60650857/64802750/e513203d9e10c067a2f02d898699b3bc/standard/download-12-thumbnail.jpg" width="75" height=""/></a></p> http://videostream.kpmg.de/photo/64802750 Tue, 05 Jan 2021 16:27:24 GMT Tax implications for life sciences companies due to Covid-19 In many life sciences companies the corona pandemic has triggered developments with tax implications: for example, accelerated digitalization and re-nationalization of supply chains. Our expert Dr. Kai Reusch explains why tax authorities in many countries are interested in digital business models and how a relocation of supply chains affects the transfer pricing system and indirect tax position. In many life sciences companies the corona pandemic has triggered developments with tax implications: for example, accelerated digitalization and re-nationalization of supply chains. Our expert Dr. Kai Reusch explains why tax authorities in many... KPMG Video Insights 02:32 <p><p>In many life sciences companies the corona pandemic has triggered developments with tax implications: for example, accelerated digitalization and re-nationalization of supply chains. Our expert Dr. Kai Reusch explains why tax authorities in many countries are interested in digital business models and how a relocation of supply chains affects the transfer pricing system and indirect tax position.</p></p><p><a href="http://videostream.kpmg.de/tax-implications-for-life-sciences"><img src="http://videostream.kpmg.de/60650857/64802750/e513203d9e10c067a2f02d898699b3bc/standard/download-12-thumbnail.jpg" width="75" height=""/></a></p> corona customs digital business models digitalization digital services taxes english input VAT life science industry life sciences companies pandemic pharmacenticals principal models supply chain tax tax authorities tax law transfer pricing VAT